ALX Oncology Holdings Inc (ALXO) is not a good buy for a beginner, long-term investor at this time. The technical indicators, options data, insider trading trends, and lack of positive catalysts suggest a weak outlook for the stock. Additionally, the absence of recent financial data, analyst ratings, or significant news further diminishes the case for investment.
The technical indicators are bearish. The MACD is below 0 and negatively contracting, the RSI is neutral at 46.744, and the moving averages indicate a bearish trend (SMA_200 > SMA_20 > SMA_5). Key support is at 1.406, and resistance is at 1.608. The stock's recent price movement shows limited upside potential.

NULL identified. There is no recent news, no AI Stock Picker or SwingMax signals, and no positive insider or institutional trading trends.
Insiders are selling heavily, with a 2135% increase in selling activity over the last month. Technical indicators are bearish, and there is no recent congress trading data or news to support a positive outlook.
No financial data is available for analysis due to an error in the provided data.
No recent analyst ratings or price target changes are available for ALXO.